Sign in
4

Changes in Ownership

Damora Therapeutics, Inc. Filed Acc 0001193125-26-403355

Director, President and CEO bought 12,500 shares at $20.23 ($252,875)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jarrett Jennifer Director, President and CEO 2026-09-25 Purchase +12,500 $20.23 $252,875 512,500 D
Open-market purchases · 12,500 sh · avg $20.23 · $252,875
Loading xslF345X06/ownership.xml…